Shana Solomon has counseled i2 Pharmaceuticals since its inception, drafting and negotiating key license and development agreements and advising the company on all aspects of its intellectual property and licensing strategy. In her nearly 20 years of practice, Ms. Solomon has developed extensive expertise drafting and negotiating strategic licensing, joint development, supply, distribution and other agreements with companies in the life science, biotechnology and pharmaceutical industries and with universities around the globe. Shana clerked for a federal judge in Washington DC and, while working in large law firms, spent the first part of her career in litigation and then moved to a transactional practice, specializing in intellectual property licensing and commercial transactions. She then moved in house, and was the VP and General Counsel for the Biosciences Division of Thermo Fisher Scientific for nearly 7 years. While at Thermo Fisher, she led a legal team that supported all facets of business units in the proteomic, genomic, cell culture and research chemical spaces with locations throughout the US and in Europe. Following her time in house, Shana founded Omics Law Group, allowing her to focus on intellectual property licensing and transactions, primarily for life science and biotechnology companies, and do cutting-edge, complex legal work for emerging growth and start-up company clients in areas that include proteomic research tools (aptamers and antibodies), diagnostics, vaccines, medical devices and anti-microbial agents. Ms. Solomon received her law degree from Cornell Law School, cum laude, in 1997, her MS degree from Rensselaer Polytechnic Institute and her BS degree from Cornell University.